Independent report · Private Markets

Swara Baby Products: ₹1,000 crore IPO filed July 2026

· By Abhinav

Subject image for Swara Baby Products

Independent report content

OFFERUp to ₹1,000 crore: fresh issue up to ₹500 crore + offer for sale up to ₹500 crore (Brainbees Solutions up to ₹300 crore; Anadya Bon Merchari LLP up to ₹200 crore); optional pre-IPO placement up to ₹100 crore
STATUSDRHP reported filed 2 Jul 2026; no SEBI approval, price band or dates found in the sources read
LEAD MANAGERSJM Financial and Avendus Capital
FY26Revenue from operations ₹1,163.9 crore (+23.4%) · profit ₹95.58 crore (+18.5%) · margin about 8.2%
FY25Revenue ₹942.97 crore · profit ₹80.67 crore (8.6%)
MARKET POSITION (DRHP, BY VALUE, FY25)37% of baby-diaper and 36% of adult-diaper contract manufacturing; "India's largest contract manufacturer of disposable hygiene products"
CAPACITYFour plants in Madhya Pradesh with 20 lines: about 2.66 billion baby diapers, 253 million adult diapers and period panties, 756 million sanitary napkins and panty liners a year
CUSTOMERS / BRANDSBrainbees Solutions (FirstCry), Piramal Pharma, Himalaya Wellness; own brands Cuddles and Shield
THE ACCESS POINT Swara Baby Products is unlisted. The IPO is the route once SEBI clears it and a price band is set. Public lists on three IPO sites did not show it among upcoming issues in the sources read, so the status should be checked against SEBI filings.

Executive decision summary

THE BOTTOM LINE Swara Baby Products makes baby and adult diapers, sanitary napkins and panty liners, mostly for other companies' brands, and says it is India's largest contract manufacturer of disposable hygiene products by value (FY25), with 37% of baby-diaper contract manufacturing. FY26 revenue was ₹1,163.9 crore (up 23.4%) and profit ₹95.58 crore (up 18.5%), a margin of about 8%. The ₹1,000 crore offer is half fresh issue and half sale; the sellers are Brainbees Solutions (which also owns FirstCry and is a customer) and Anadya Bon Merchari LLP. A contract manufacturer has volume and cost advantages but little pricing power or brand: the questions are customer concentration, the share of own brands and how much of the new money is spent on a fresh plant and debt repayment, none of which carries amounts in the sources read.
WHICH INVESTOR Fits you IF you want a scale manufacturer in a consumer category with structural volume growth and an asset base that supports brand-owner outsourcing. Look elsewhere IF you want brand pricing power or high margins: contract manufacturing earns thin margins and depends on a few customers.
COMFORT FIT Swara = the factory behind brands: it makes diapers that carry other companies' names, plus Cuddles and Shield of its own. Brainbees (FirstCry) = both a customer and a selling shareholder, so its interests are on both sides. Contract manufacturing = steady volume, low margin and high dependence on a few buyers.
THE RUPEIA NUMBER 37%. Share of baby-diaper contract manufacturing by value in FY25 (company-reported, DRHP).

1 CLAIM REGISTER: EVIDENCE GRADING

A = government or regulator record. B = statutory filing. C = independent press. D = company announcement.

ClaimSourceGradeRupeia assessment
Offer ₹1,000 crore: fresh ≤₹500 crore + OFS ≤₹500 crore; sellers Brainbees ≤₹300 crore and Anadya Bon Merchari ≤₹200 crore; pre-IPO ≤₹100 croreBusiness Today (2 Jul 2026)BSingle article read.
Lead managers JM Financial and Avendus CapitalBusiness TodayBRegistrar not found.
Revenue ₹1,163.9 / 942.97 crore; profit ₹95.58 / 80.67 crore (FY26 / FY25)Business Today, from the DRHPBConsolidated or standalone not stated; FY24 not found.
37% baby-diaper and 36% adult-diaper contract manufacturing share by value, FY25Business Today (DRHP)CCompany-reported, industry-report basis.
Four plants, 20 lines; capacity 2.66 billion baby diapers, 253 million adult diapers/period panties, 756 million napkins/linersBusiness TodayB/CReported.
Founded 2018; acquired K.A. Enterprises Hygiene in December 2025Business TodayB/CPrice not given.
Customers Brainbees Solutions, Piramal Pharma, Himalaya WellnessBusiness TodayB/CShares of revenue not given.
No SEBI observation, RHP or listing foundChittorgarh, Kotak Neo, Groww list pagesCLists may lag; verify with SEBI.

2 COMPANY OVERVIEW & FOUNDING STORY

Swara Baby Products was founded in 2018 and makes baby diapers, adult diapers, sanitary napkins and panty liners. It manufactures for other brands and sells its own Cuddles and Shield brands. It operates four manufacturing facilities with 20 production lines in Madhya Pradesh and acquired K.A. Enterprises Hygiene in December 2025.

Customers named in the DRHP include Brainbees Solutions (the parent of the baby-products retailer FirstCry), Piramal Pharma and Himalaya Wellness. Brainbees is also a selling shareholder in the OFS, which links one of its largest customers to the exit.

The fresh issue is intended to fund a new manufacturing facility in Madhya Pradesh, repay borrowings, invest in subsidiaries to repay their debt, make acquisitions and meet general purposes. Amounts per object, promoters' holdings and headquarters were not found in the sources read.

3 TIMELINE

DateEvent
2018Founded
FY25Revenue ₹942.97 crore; profit ₹80.67 crore; largest contract manufacturer of disposable hygiene products by value (DRHP claim)
Dec 2025Acquires K.A. Enterprises Hygiene
FY26Revenue ₹1,163.9 crore (+23.4%); profit ₹95.58 crore (+18.5%)
2 Jul 2026DRHP filing reported (₹1,000 crore)
Nov 2026No SEBI observation or price band found

4 OFFER STRUCTURE AND SELLERS

ItemDetailFigureComment
Fresh issueNew sharesUp to ₹500 crorePlant, debt repayment, acquisitions, general purposes
Offer for saleSelling shareholdersUp to ₹500 croreBrainbees ≤₹300 crore; Anadya Bon Merchari ≤₹200 crore
Pre-IPO placementOptionalUp to ₹100 croreWhether it reduces the fresh issue is not stated
Lead managersBRLMsJM Financial, Avendus Capital—
Price band, dates, registrarNot announced——

Brainbees is selling 60% of the OFS (₹300 crore of ₹500 crore) and the offer is split evenly between company money and seller money.

RUPEIA CALCULATION Half the offer (₹500 crore) goes to the sellers and half to the company. At FY26 profit of ₹95.58 crore, ₹500 crore of fresh money is 5.2 times annual profit, so the use of proceeds is material. Without amounts for the plant and debt repayment, the effect on leverage cannot be computed; the RHP should show them.

5 FINANCIAL FORENSICS: GROWTH WITH A THIN MARGIN

₹ croreFY25FY26Change
Revenue from operations942.971,163.9+23.4%
Net profit80.6795.58+18.5%
PAT margin (Rupeia)8.6%8.2%−0.3 pt
EBITDA, debt, cash flowNot foundNot found—
FY24 revenue and profitNot found——

Revenue grew faster than profit, so margin slipped slightly. The acquisition of K.A. Enterprises Hygiene in December 2025 will add to FY26 and FY27 revenue; whether any of the 23.4% growth is acquired is not stated. EBITDA and net debt are missing, so the true leverage and return on capital cannot be assessed.

RUPEIA CALCULATION Margin sensitivity. At FY26 revenue of ₹1,163.9 crore, each 1 percentage point of net margin is about ₹11.6 crore of profit. A fall of the margin from 8.2% to 6.2% would take profit from ₹95.58 crore to about ₹72.2 crore, a drop of 24%. Contract manufacturers are exposed to raw-material costs (fluff pulp, super-absorbent polymer, non-woven fabric), where price changes pass through to customers with a lag. This is a Rupeia illustration, not a forecast.

6 BUSINESS MODEL & UNIT ECONOMICS

Swara earns by manufacturing disposable hygiene products for others and for its own brands.

LineHow it earnsPressure point
Baby diapers (contract)37% of contract manufacturing by value; 2.66 billion pieces of capacityBrand owners can switch or insource
Adult diapers (contract)36% share; 253 million pieces (with period panties)Smaller category; institutional buyers
Sanitary napkins and panty liners756 million pieces of capacityPrice-sensitive; competition from established brands
Own brands (Cuddles, Shield)Higher margin if scaledNeeds marketing and distribution
Acquired capacity (K.A. Enterprises Hygiene)Added in December 2025Integration; price not disclosed

Contract manufacturing converts materials into finished goods for brand owners at a negotiated price per unit. High utilisation across 20 lines and long-term supply agreements are what protect margin.

7 MARKET & COMPETITIVE ANALYSIS

PeerStatusPosition
Procter & Gamble Hygiene and Health CareListedPampers and Whisper brand owner; Rupeia context, no figures sourced
Kimberly-Clark, UnicharmGlobalHuggies and MamyPoko brand owners
Himalaya, FirstCry (Brainbees)Private / listedBrand owners and customers
Other Indian hygiene contract makersPrivateNot named in the sources read

The sources do not give listed peer multiples for contract manufacturers. The comparison set is brand owners (higher margin, advertising-heavy) and other contract makers (lower margin); the correct benchmark is closer to the latter.

8 1. CONTRACT MANUFACTURING VERSUS OWNING A BRAND

A brand owner such as FirstCry decides price, marketing and shelf placement, and pays a manufacturer a per-unit price. The manufacturer wins scale and steady volume but gives up brand value. Swara's own brands, Cuddles and Shield, are the route to higher margins, but they compete with national brands that spend heavily on advertising.

FeatureContract manufacturerBrand owner
Pricing powerLow; negotiated per unitHigher; set at shelf
Marketing spendLowHigh
Customer concentrationOften highSpread across consumers
Capital intensityHigh (lines, plants)Lower if outsourcing
Typical marginSingle-digit to low-teens netHigher but more volatile

General description by Rupeia; Swara's margin is about 8%.

9 2. CAPACITY AND UTILISATION

ProductAnnual capacitySource
Baby diapers~2.66 billion piecesBusiness Today (DRHP)
Adult diapers and period panties~253 million piecesBusiness Today
Sanitary napkins and panty liners~756 million piecesBusiness Today
Plants / linesFour facilities, 20 lines, Madhya PradeshBusiness Today
Capacity utilisationNot found—
New plant (fresh issue)Madhya Pradesh; cost and capacity not foundBusiness Today
RUPEIA CALCULATION Rupeia calculation: if all capacity were baby diapers, 2.66 billion pieces over 20 lines is about 133 million pieces a line a year, but lines are not interchangeable and capacity is shared across products. At FY26 revenue of ₹1,163.9 crore, revenue per line is about ₹58 crore (₹1,163.9 crore ÷ 20). Both figures are crude averages, not company data.

10 3. CUSTOMERS AND RELATED-PARTY ANGLE

Brainbees Solutions: customer and selling shareholder (≤₹300 crore of the OFS). The RHP should show its share of revenue and the pricing terms.

Piramal Pharma and Himalaya Wellness: named customers; shares of revenue not given.

Concentration test: the top five customers' share of revenue and the contract terms (tenor, price pass-through, minimum volume) are the key items.

Anadya Bon Merchari LLP: a selling shareholder; identity and holding not given in the sources read.

When a seller in the OFS is also a leading customer, the market will want to see that price and volume commitments survive the exit.

11 4. USE OF THE FRESH ISSUE

ObjectAmountWhat it means
New plant, Madhya PradeshNot shownCapacity expansion; depends on utilisation
Repay borrowingsNot shownReduces interest cost; leverage unknown
Investment in subsidiaries for debt repaymentNot shownDebt may sit in subsidiaries
Inorganic acquisitionsNot shownFurther deals like K.A. Enterprises
General corporate purposesNot shownResidual

None of the object amounts appeared in the sources read. A fresh issue of up to ₹500 crore against FY26 profit of ₹95.58 crore is large enough that the split between growth and debt repayment decides how much of the proceeds improves returns.

12 5. VALUATION GRID

Post-issue value (₹ crore)P/E on ₹95.58 crx revenue ₹1,163.9 cr₹1,000 cr as % of equity
2,00020.9x1.7x50.0%
3,00031.4x2.6x33.3%
4,00041.9x3.4x25.0%
5,00052.3x4.3x20.0%

No valuation has been published. Rupeia arithmetic.

RUPEIA CALCULATION Rupeia calculation: at 31x earnings (₹3,000 crore) the offer would be a third of the company, an unusually large float for a mainboard issue. At that value the fresh issue of ₹500 crore is 16.7% and the OFS 16.7% of post-issue equity. A contract manufacturer with an 8% net margin would normally be valued below a brand owner on revenue (2.6x here), so the grid shows where the multiple would feel stretched.

13 6. INDUSTRY CONTEXT (WITHOUT FIGURES THE SOURCES DID NOT GIVE)

Disposable hygiene products in India have low penetration relative to developed markets and are sold through general trade, modern retail and e-commerce. The sources read give no market-size or growth figures for diapers or napkins; the DRHP's industry report would. What the sources do show is a manufacturer that has taken about a third of contract manufacturing in two categories, which implies that brand owners are outsourcing production at scale.

14 7. RISK MAP

RiskMechanismWhere to look in the RHP
Customer concentrationA few brand owners dominate salesTop customer share
Raw-material costsPulp, polymer and non-woven pricesMaterial cost share and pass-through terms
Thin marginContract pricing leaves ~8% net marginMargin by product and customer
Related-party salesBrainbees is customer and sellerRelated-party note
Integration riskK.A. Enterprises Hygiene acquired December 2025Contribution and price
Capacity overbuildNew plant adds supply if demand lagsUtilisation by plant
Regulatory and qualityHygiene and baby-care product standardsApprovals and recalls

15 8. QUESTIONS FOR THE RED HERRING PROSPECTUS

Revenue by product, customer and own-brand versus contract for FY24–FY26.

EBITDA, net debt, interest cost and cash flow.

Amounts for each object of the fresh issue.

Promoters, holdings and the identity of Anadya Bon Merchari LLP.

Contract terms with Brainbees, Piramal Pharma and Himalaya Wellness.

Capacity utilisation and the cost and size of the new plant.

Purchase price and contribution of K.A. Enterprises Hygiene.

SEBI observation date and validity.

16 9. GLOSSARY

TermMeaning
Contract manufacturingMaking goods for another company's brand
Panty liner / period pantyHygiene products in the sanitary-care range
Fluff pulp / SAP / non-wovenMain raw materials in diapers
OFS / fresh issueSale by existing holders versus new shares
Pre-IPO placementPrivate placement before the public offer

17 VALUATION SCENARIOS

ScenarioPost-issue value (₹ crore)P/E on FY26What must be true
Bear2,00020.9xThin margin and concentration dominate
Base3,00031.4xSteady 20% growth and clear use of proceeds
Bull4,50047.1xOwn brands scale and margin rises

Rupeia scenarios; no valuation has been published.

18 SCENARIO ANALYSIS

ScenarioProbabilityWhat happens
Bull20%SEBI clears the issue; own brands lift margin; IPO at 40x+
Base45%IPO at 25–35x earnings; margins hold near 8%
Bear35%Approval delay or weak markets; concentration concerns reduce the price

19 RISK ANALYSIS: RED FLAG LEDGER & KILL CONDITIONS

RiskSeverityKill condition
Customer concentration and related-party salesHighTop customer share; Brainbees terms
Thin margin and raw-material swingsHighNet margin below 7%
SEBI status unconfirmedMediumObservation letter and validity
Capacity expansion executionMediumNew plant cost and utilisation
Acquisition integrationMediumK.A. Enterprises contribution
Missing data (EBITDA, debt, FY24)MediumRHP disclosure

20 INVESTOR CLASS ANALYSIS

HNIs and family offices

Wait for the RHP. The decisive items are customer concentration, Brainbees' contract terms and the use-of-funds split; a thin-margin contract manufacturer should be priced below a brand owner.

Institutions

Institutions will test customer stickiness, raw-material pass-through and the case for the new plant.

NRIs

NRIs can hold unlisted Indian shares under FEMA pricing and reporting rules; repatriation depends on the account route used.

21 THE EARLY SIGNAL: EVENTS TO WATCH

WhenEvent
Q4 2026–2027SEBI observations (if not already received); RHP
OptionalPre-IPO placement up to ₹100 crore
Post-listingFirst quarterly results

22 RUPEIA FINAL INDEPENDENT VIEW

Swara has scale, share and growth in a category brands are outsourcing. A margin of about 8%, an unconfirmed regulatory status and a customer that is also a seller are the reasons to wait for the prospectus.

THE RUPEIA NUMBER 37%. Share of baby-diaper contract manufacturing by value in FY25 (company-reported, DRHP).
RUPEIA VERDICT Scale manufacturer with thin margin. Wait for the RHP.

Frequently asked questions

How big is Swara Baby Products' IPO?

Up to ₹1,000 crore: ₹500 crore fresh and ₹500 crore offer for sale.

Who is selling?

Brainbees Solutions (up to ₹300 crore) and Anadya Bon Merchari LLP (up to ₹200 crore).

What are Swara's revenue and profit?

FY26 revenue ₹1,163.9 crore and profit ₹95.58 crore, up 23.4% and 18.5%.

What does Swara make?

Baby and adult diapers, sanitary napkins and panty liners, mostly as a contract manufacturer, plus the Cuddles and Shield brands.

Has SEBI approved the IPO?

The sources read show a DRHP filing in July 2026 but no observation letter.

Source log

Business Today: Swara Baby, TMC Transformers, Ratnadeep Retail file DRHPs

Chittorgarh: upcoming IPOs with DRHP filed

Kotak Neo: upcoming IPOs

Groww: upcoming IPOs

DISCLAIMER This report is independent research by Rupeia Investments Co. built only from public sources as of the date shown. It is not an offer, solicitation or investment advice, and it is not a recommendation to buy or sell any security. Private-company figures are drawn from filings and media reports and may be revised. Unlisted and private-market investments are illiquid and carry a risk of total loss. Investors should take independent advice.